NASDAQ:HUMAW

Humacyte (HUMAW) Stock Forecast, Price & News

$0.99

-0.01 (-1.00%)

(As of 06/7/2023 ET)

Today's Range: $0.89
▼
$0.99
50-Day Range: $0.50
▼
$1.04
52-Week Range: $0.38
▼
$1.53

Volume: 204 shs
Average Volume: 13,199 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Financials Institutional Ownership Headlines SEC Filings Short Interest Social Media

Receive HUMAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter.

HUMAW Stock News Headlines

May 30, 2023 | americanbankingnews.com

Humacyte, Inc. (NASDAQ:HUMAW) Sees Large Growth in Short Interest

April 19, 2023 | americanbankingnews.com

Short Interest in Humacyte, Inc. (NASDAQ:HUMAW) Expands By 42.2%

June 8, 2023 | Edge On The Street (Ad)

Graphite Shortage Could Derail the $7 Trillion EV Transition

Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.

March 30, 2023 | americanbankingnews.com

Humacyte, Inc. (NASDAQ:HUMAW) Sees Significant Growth in Short Interest

See More Headlines

HUMAW Price History

30 days | 90 days | 365 days | Advanced Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: N/A
Sub-Industry: N/A
Sector: N/A
Current Symbol: NASDAQ:HUMAW
CUSIP: N/A
CIK: 1818382
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Institutional Ownership

View All Institutional Transactions

HUMAW Stock - Frequently Asked Questions

How have HUMAW shares performed in 2023?: Humacyte's stock was trading at $0.3926 at the start of the year. Since then, HUMAW shares have increased by 152.2% and is now trading at $0.99.
View the best growth stocks for 2023 here.
Are investors shorting Humacyte?: Humacyte saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 11,700 shares, an increase of 7.3% from the April 30th total of 10,900 shares. Based on an average trading volume of 13,100 shares, the short-interest ratio is currently 0.9 days.
View Humacyte's Short Interest.

What is Humacyte's stock symbol?: Humacyte trades on the NASDAQ under the ticker symbol "HUMAW."
Who are Humacyte's major shareholders?: Humacyte's stock is owned by many different retail and institutional investors. Top institutional investors include CVI Holdings LLC (0.00%) and Sio Capital Management LLC (0.00%).
How do I buy shares of Humacyte?: Shares of HUMAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Humacyte's stock price today?: One share of HUMAW stock can currently be purchased for approximately $0.99.

This page (NASDAQ:HUMAW) was last updated on 6/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial